Silverfin false 28/02/2023 28/02/2023 01/03/2022 The principal activity of the Company during the financial year was specialist medical practice activities. Lucy Josephine Dale 18/02/2020 Dr Oliver Thomas Dale 18/02/2020 12470054 2023-02-28 12470054 bus:Director1 2023-02-28 12470054 bus:Director2 2023-02-28 12470054 2022-02-28 12470054 core:CurrentFinancialInstruments 2023-02-28 12470054 core:CurrentFinancialInstruments 2022-02-28 12470054 2022-03-01 2023-02-28 12470054 bus:Micro-entities 2022-03-01 2023-02-28 12470054 bus:FullAccounts 2022-03-01 2023-02-28 12470054 bus:AuditExemptWithAccountantsReport 2022-03-01 2023-02-28 12470054 bus:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28 12470054 bus:Director1 2022-03-01 2023-02-28 12470054 bus:Director2 2022-03-01 2023-02-28 12470054 2021-03-01 2022-02-28 iso4217:GBP xbrli:pure

Company No: 12470054 (England and Wales)

BRISTOL ENT SURGERY LIMITED

Unaudited Financial Statements
For the financial year ended 28 February 2023
Pages for filing with the registrar

BRISTOL ENT SURGERY LIMITED

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 28 February 2023

Contents

BRISTOL ENT SURGERY LIMITED

BALANCE SHEET

As at 28 February 2023
BRISTOL ENT SURGERY LIMITED

BALANCE SHEET (continued)

For the financial year ended 28 February 2023
2023 2022
£ £
Fixed assets 1,628 2,786
Current assets 226,864 94,648
Creditors: amounts falling due within one year ( 37,495) ( 24,080)
Net current assets 189,369 70,568
Total assets less current liabilities 190,997 73,354
Accruals and deferred income ( 1,333) ( 1,213)
Net assets 189,664 72,141
Capital and reserves 189,664 72,141

For the financial year ending 28 February 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Bristol ENT Surgery Limited (registered number: 12470054) were approved and authorised for issue by the Board of Directors on 16 November 2023 and were signed on its behalf by:

Dr Oliver Thomas Dale
Director
BRISTOL ENT SURGERY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 28 February 2023
BRISTOL ENT SURGERY LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 28 February 2023

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 12470054). The address of its registered office is 25 King Street, Bristol, BS1 4PB, United Kingdom.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 2 2

3. Directors’ benefits: advances, credit and guarantees

Advances

The Directors loan account is repayable on demand and interest is charged on overdrawn balances exceeding £10,000 at the official HMRC rates.

At 1 March 2022, the balance owed by the director was £14,910. During the year, £27,710 was advanced to the director, and £1,117 was repaid by the director. At 28 February 2023, the balance owed by the director was £41,503.

At 1 March 2021, the balance owed to the director was £726. During the year, £19,841 was advanced to the director, and £4,205 was repaid by the director. At 28 February 2022, the balance owed by the director was £14,910.